| http://dbpedia.org/ontology/abstract
|
LBT-3627 is an experimental peptide drug d … LBT-3627 is an experimental peptide drug derived from vasoactive intestinal peptide (VIP) that can change the behavior of immune cells so they protect dopamine-producing cells rather than attacking them. The drug is being studied for its potential use for Parkinson's disease.its potential use for Parkinson's disease.
, LBT-3627؛ هو دواءٌ ببتيد تجريبيٌّ مُستمَد من الببتيد المعوي الفعَّال وعائيًّا، والذي يستطيع تغيير سلوك الخلايا المناعية؛ لحماية الخلايا المُنتِجة للدوبامين بدلاً من مهاجمتها. تتم دراسة العقار لاستخدامه المحتمل لمرض باركنسون.
|
| http://dbpedia.org/ontology/wikiPageID
|
48855017
|
| http://dbpedia.org/ontology/wikiPageLength
|
2858
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1073190258
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Vasoactive_intestinal_peptide_receptor +
, http://dbpedia.org/resource/Category:Receptor_agonists +
, http://dbpedia.org/resource/Peptide +
, http://dbpedia.org/resource/Phase_I_trial +
, http://dbpedia.org/resource/Dopamine +
, http://dbpedia.org/resource/Vasoactive_intestinal_peptide +
, http://dbpedia.org/resource/Microglia +
, http://dbpedia.org/resource/Preclinical_development +
, http://dbpedia.org/resource/University_of_Nebraska_Medical_Center +
, http://dbpedia.org/resource/Parkinson%27s_disease +
, http://dbpedia.org/resource/Category:Peptides +
, http://dbpedia.org/resource/Category:Antiparkinsonian_agents +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Antiparkinson +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Antiparkinsonian_agents +
, http://dbpedia.org/resource/Category:Peptides +
, http://dbpedia.org/resource/Category:Receptor_agonists +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Drug +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/LBT-3627?oldid=1073190258&ns=0 +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/LBT-3627 +
|
| owl:sameAs |
http://dbpedia.org/resource/LBT-3627 +
, http://yago-knowledge.org/resource/LBT-3627 +
, http://ar.dbpedia.org/resource/LBT-3627 +
, https://global.dbpedia.org/id/2PA5x +
, http://www.wikidata.org/entity/Q25323805 +
|
| rdf:type |
http://dbpedia.org/ontology/Drug +
|
| rdfs:comment |
LBT-3627؛ هو دواءٌ ببتيد تجريبيٌّ مُستمَد من الببتيد المعوي الفعَّال وعائيًّا، والذي يستطيع تغيير سلوك الخلايا المناعية؛ لحماية الخلايا المُنتِجة للدوبامين بدلاً من مهاجمتها. تتم دراسة العقار لاستخدامه المحتمل لمرض باركنسون.
, LBT-3627 is an experimental peptide drug d … LBT-3627 is an experimental peptide drug derived from vasoactive intestinal peptide (VIP) that can change the behavior of immune cells so they protect dopamine-producing cells rather than attacking them. The drug is being studied for its potential use for Parkinson's disease.its potential use for Parkinson's disease.
|
| rdfs:label |
LBT-3627
|
